Where do we stand on quality of life?  Worldwide, several thousand diseases affect humans of which only about five hundred have any treatment, more than seven hundred million people suffer from malnutrition, health care for aging people and related diseases concern more than one billion people and more such issues are at stake.
With you and our partners, our vision and our values, we have the ambition to create with the ‘Health from Space’ conference a platform for the accelerated discoveries of therapies and advances in quality of life, for individuals as well as humankind globally. Indeed, the life sciences, health and related biomaterial domains, are on the verge of a disruptive evolution, actually a revolution, thanks to the possibility to establish and operate facilities in the environment of space.

Oddly enough, most of the actors in these domains are unaware of these coming dramatic changes and it will happen that, even though the pharmaceutical and cosmetics industries can be considered fully mature with turnovers each of more than one trillion per year and hundreds of millions of dollars in research and development annually, the new environment offered by space is poised to dramatically impact those numbers positively. The potential scientific, technological, and commercial benefits of microgravity research and development as well as manufacturing in space are considerable and will revolutionize traditional Earth-bound development and processing methods for these whole sectors.

This revolution will stem both from the easier access to space in terms of cost and flight opportunities, and from the new space platforms and private stations planned to be launched from all over the world. Together with the new advanced and miniaturized laboratories, these will provide researchers and industry alike with exceptional opportunities to conduct experiments in a disruptive microgravity environment that will meet scientific and manufacturing principal standards. The resulting number of applications is expected to increase drastically from new therapeutics to anti-aging, regenerative medicine, and to stem cell research in general to name just a few. The whole pharmaceutical, cosmetics, medical, biotechnology and biomaterial industries will become major participants in the frame of the commercialization of space.

As key actors of these domains, we invite you to attend this high-level event which is expected to gather several hundred participants including worldwide experts and investors as well as CEOs and other C-Level executives from the Pharma, Cosmetics, Biotechnology, Nutrition, Medical and Advanced Biomaterials Industry. Heads of Scientific Institutions and Space Agencies, as well as other Government Officials will share in discussions on how to foster these innovations.